Thursday, December 10, 2020

FDA Committee Votes to Recommend Urgent Use of Pfizer Vaccine

The Food and Drug Administration's advisory panel on Thursday recommended the emergency use of Pfizer's COVID-19 vaccine. If the vaccine is authorized by the FDA, the first shots could be distributed in the U.S. within days. Health care workers and nursing home residents would be among the first in line.

The panel of outside experts reviewed trial data from Pfizer's vaccine and made its recommendation to the FDA this afternoon.

Nancy Messonnier, a senior CDC official, said "active surveillance systems" will be in place to monitor the safety of vaccine recipients — specifically health care workers and long-term care facility residents — to track any potential adverse side effects. She said the systems will provide useful information about how the vaccine is affecting different communities.

No comments:

Post a Comment

Genuine commenting is warmly welcomed--Advertising is not welcome in the Comment Section and will be removed without further explanation.